Bottom line
What is JRTBX's expense ratio?
JRTBX's expense ratio is 0.39%, or about $39 a year on every $10,000 invested. That is cheaper than 72% of target-date funds we track (median 0.59%). Its expense ratio includes a 0.05% 12b-1 marketing fee.
Updated Dec 23, 2025
JRTBX fee table
| Net expense ratio | 0.39% |
|---|---|
| Gross expense ratio | 0.76% |
| Management fee | 0.35% |
| 12b-1 (distribution) fee | 0.05% |
| Other expenses | 0.06% |
| Acquired fund fees | 0.3% |
| Fee waiver / reimbursement | -0.37% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What JRTBX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| JRTBX | $40 | $206 | $386 | $908 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.39% expense ratio costs roughly $22,800 in lost growth, versus about $33,900 for the median target-date fund (0.59%).